AMED - アメディシス （Amedisys Inc）

In last trading session, Amedisys Inc. (NASDAQ:AMED) saw 0.21 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level of $91.04 trading at -$0.21 or -0.23% at ring of the bell on the day assigns it a market valuation of $2.92B. That closing price of AMED’s stock is at … Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? Read More »

Amedisys (AMED) names Scott Ginn, Executive VP and CFO, its acting COO, effective immediately.Ginn has led financial teams since 2007, serving as senior VP of Accounting and Controller…

Baton Rouge-based home health care company Amedisys says it fired CEO Christopher Gerard and replaced him with former CEO Paul Kusserow.

The company''s chairman will act as interim CEO until a successor is found.

Home health and hospice company brings on former leader in interim role

In last trading session, Amedisys Inc. (NASDAQ:AMED) saw 0.21 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level of $91.04 trading at -$0.21 or -0.23% at ring of the bell on the day assigns it a market valuation of $2.92B. That closing price of AMED’s stock is at … Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? Read More »

Amedisys (AMED) names Scott Ginn, Executive VP and CFO, its acting COO, effective immediately.Ginn has led financial teams since 2007, serving as senior VP of Accounting and Controller…

Baton Rouge-based home health care company Amedisys says it fired CEO Christopher Gerard and replaced him with former CEO Paul Kusserow.

The company''s chairman will act as interim CEO until a successor is found.

Home health and hospice company brings on former leader in interim role

BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 28, 2022.

Launching its coverage on Amedisys (AMED) and Addus HomeCare (ADUS), Stifel issues a contrasting view on the two home health care companies after the Centers for Medicare and…

Amedisys (AMED) stock fell ~13% on June 21 after Bank of America downgraded the stock to Underperform from Neutral with a price target of $102, from $145, following Centers for Medicare…

Technical analysis for Amedisys AMED including support levels resistance levels and stop losses for AMED

Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ: AMED ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 2 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 1 0 0 According to 5 analyst offering 12-month price targets in the last 3 months, Amedisys has an average price target of $155.6 with a high of $182.00 and a low … Full story available on Benzinga.com